ing 9: efts on newborn have been rptd from a single expos ing 10: abnorm bleeding, gastric ulceration, weight loss, ing 11: were rptd after ingest of 8-20 grams in course of ing 12: several hrs. blindness lasted 3-24 hrs. however, ing 13: incl narrowing of visual fields, hemianopsia & ing 14: been rptd from repeated admin to rats/mice. efts on first aid proc: saline, occas lifting upper/lower lids, ing 16: get med attn immed. ingest: if conscious & not ing 17: by water. if vomit occurs keep head below hips to ing 18: give activated charcoal. in patients w/depress resp ing 19: cautiously. treat symptomatically/ supportively. ing 20: personnel. get medical attention immediately. no other prot equip: the immediate work area for emergency ing 8: devel abnorm have been rptd from a single expos to salicylic acid, monosodium salt; (sodium salicylate) supp data: alterations in acid-base balance. convl/coma may ing 2: sweating/vomit & loss of water vap from hypervent. ing 3: phenomena are occas seen & may consist of petechial ing 4: rarely thrombocytopenic purpura, & bleeding from ing 5: encephalopathy may also occur. as poisoning ing 6: depress, stupor & coma. cardiovascular collapse & ing 7: uremia & pulm edema sometimes appear. death may rslt
LD50 LC50 Mixture:LD50: (ORAL, RAT) 1200 MG/KG
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:SODIUM SALICYLATE IS A POWERFUL
IRRITANT/CNS DEPRESSANT. INHAL: ACUTE/CHRONIC-NO DATA AVAIL. SKIN:
ACUTE-MAY CAUSE IRRIT/SENSIT W/RASHES & SKIN ERUPTIONS. IT IS
ABSORBED THRU SKIN & MAY CAUSE SYMPTOMS AS IN ACUTE INGEST.
CHRONIC-RPTD/PRLNGCONT MAY CAUSE SENSIT DERMAT & SYMPTOMS AS IN
CHRONIC INGEST. (EFTS OF OVEREXP)
Explanation of Carcinogenicity:NOT RELEVANT.
Effects of Overexposure:HLTH HAZ: EYE: ACUTE/CHRONIC-NO DATA AVAIL.
INGEST: ACUTE-MAY CAUSE BURNING PAIN IN MOUTH/GI IRRIT. EXPOS TO
VERY EXCESSIVE AMTS OF SALICYLATES MAY CAUSE HDACH/DIZZ/RINGING IN
EARS/DFCLTY IN HEARING/D IMNESS OF VISION/MENTAL
CONFUSION/LASS/DROW/SWEATING/THIRST/NAUS/VOMIT/HYPERVENT/FLUID
RETENTION & OCCAS (SUPP DATA)
Medical Cond Aggravated by Exposure:NONE SPECIFIED BY MANUFACTURER.
======================= First Aid Measures =======================
First Aid:INHAL: REMOVE FROM EXPOS AREA TO FRESH AIR IMMED. IF BRTHG
HAS STOPPED, PERFORM ARTF RESP. KEEP WARM/AT REST. TREAT
SYMPTOMATICALLY/SUPPORTIVELY. GET MED ATTN IMMED. SKIN: REMOVE
CONTAMD CLTHG/ SHOES IMMED. WASH AFFECTED AREA W/SOAP OR MILD
DETERGENT & LG AMTS OF WATER UNTIL NO EVIDENCE OF CHEM REMAINS
(APPROX 15-20 MIN). GET MED ATTN IMMED. EYES: WASH IMMED W/LG AMTS
OF WATER OR NORMAL (ING 16)
===================== Fire Fighting Measures =====================
Extinguishing Media:DRY CHEMICAL, CARBON DIOXIDE, WATER SPRAY OR
REGULAR FOAM. FOR LARGER FIRES, USE WATER SPRAY, FOG OR REGULAR
FOAM.
Fire Fighting Procedures:MOVE CONTR FROM FIRE AREA IF YOU CAN DO IT W/O
RISK. DO NOT SCATTER SPILLED MATL W/HIGH-PRESS WATER STREAMS. DIKE
FIRE-CTL WATER FOR LATER DISPOSAL. (SUPP DATA)
Unusual Fire/Explosion Hazard:SLIGHT FIRE HAZARD WHEN EXPOSED TO HEAT
OR FLAME.
Spill Release Procedures:SWEEP UP AND PLACE IN SUITABLE CLEAN, DRY
CONTAINERS FOR RECLAMATION OR LATER DISPOSAL. DO NOT FLUSH SPILLED
MATERIAL INTO SEWER. KEEP UNNECESSARY PEOPLE AWAY.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.
====================== Handling and Storage ======================
Handling and Storage Precautions:KEEP CONTAINER TIGHTLY CLOSED. PROTECT
FROM EXPOSURE TO AIR OR LIGHT. OBSERVE ALL FEDERAL, STATE AND LOCAL
REGULATIONS WHEN STORING THIS SUBSTANCE.
Other Precautions:NONE SPECIFIED BY MANUFACTURER.
Respiratory Protection:HIGH LEVELS - NIOSH/MSHA APPROVED DUST MASK.
Ventilation:PROVIDE LOCAL EXHAUST OR GENERAL DILUTION VENTILATION
SYSTEM.
Protective Gloves:IMPERVIOUS GLOVES .
Eye Protection:CHEM WORK GOGG/FULL LENGTH FSHLD .
Other Protective Equipment:IMPERVIOUS CLTHG/EQUIP TO PVNT RPTD/PRLNG
SKIN CONT W/SUBSTANCE. EYE WASH FOUNTAIN/QUICK DRENCH SHOWER WITHIN
(ING 22)
Work Hygienic Practices:NONE SPECIFIED BY MANUFACTURER.
Supplemental Safety and Health
FIRE FIGHT PROC: USE AGENTS SUITABLE FOR TYPE OF SURROUNDING FIRE.
AVOID BRTHG HAZ VAPS. KEEP UPWIND. WEAR NIOSH/MSHA APPRVD PRESS
DEMAND SCBA & FULL PROT EQUIP . EFTS OF OVEREXP: DIARR. A MORE SEV
DEGREE OF SALICYLATE INTOX IS CHARACT BY MORE PRONOUNCED CNS
DISTURB/CARDIAC ABNORM/SKIN ERUPTIONS & MARKED (ING 2)
HCC:C3
pH:5-6
Solubility in Water:111%
Appearance and Odor:ODORLESS WHITE CRYSTALS OR AMORPHOUS POWDER WITH A
SLIGHT SALINE TASTE.
================= Stability and Reactivity Data =================
Stability Indicator/Materials to Avoid:YES
AVOID CONTACT WITH STRONG OXIDIZERS.
Stability Condition to Avoid:STABLE UNDER NORMAL TEMP/PRESS. MAY BURN
BUT DOES NOT IGNITE READILY. AVOID EXCESSIVE HEAT, SPARKS, OR OPEN
FLAME.
Hazardous Decomposition Products:THERMAL DECOMPOSITION PRODUCTS MAY
INCLUDE TOXIC OXIDES OF CARBON.
Waste Disposal Methods:OBSERVE ALL FEDERAL, STATE AND LOCAL REGULATIONS
WHEN DISPOSING THIS SUBSTANCE. FOR ASSISTANCE, CONTACT THE DISTRICT
DIRECTOR OF THE ENVIRONMENTAL PROTECTION AGENCY.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.